SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-218655
Filing Date
2006-10-31
Accepted
2006-10-31 07:33:14
Documents
9
Period of Report
2006-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16920
2 FORM OF NOTE dex41.htm EX-4.1 139790
3 FORM OF PIK NOTE dex42.htm EX-4.2 143626
4 PLEDGE AND SECURITY AGREEMENT dex43.htm EX-4.3 51736
5 GUARANTY DATED OCTOBER 30, 2006 (ANTIGENICS) dex44.htm EX-4.4 60019
6 GUARANTY DATED OCTOBER 30, 2006 (ARONEX) dex45.htm EX-4.5 58734
7 SECURITIES PURCHASE AGREEMENT dex46.htm EX-4.6 132793
8 PRESS RELEASE dex991.htm EX-99.1 7841
9 GRAPHIC g61567img001.jpg GRAPHIC 80414
  Complete submission text file 0001193125-06-218655.txt   723959
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 061173830
SIC: 2836 Biological Products, (No Diagnostic Substances)